Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 408

Showing 1-25 of 408 citing articles:

T cell responses to SARS-CoV-2 spike cross-recognize Omicron
Roanne Keeton, Marius B. Tincho, Amkele Ngomti, et al.
Nature (2022) Vol. 603, Iss. 7901, pp. 488-492
Open Access | Times Cited: 548
SARS-CoV-2 Omicron variant: recent progress and future perspectives
Yao Fan, Xiang Li, Lei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 484
Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 472
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 179
The Evolution and Biology of SARS-CoV-2 Variants
Amalio Telenti, Emma B. Hodcroft, David L. Robertson
Cold Spring Harbor Perspectives in Medicine (2022) Vol. 12, Iss. 5, pp. a041390-a041390
Open Access | Times Cited: 159
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Alexander Wilhelm, Marek Widera, Katharina Grikscheit, et al.
EBioMedicine (2022) Vol. 82, pp. 104158-104158
Open Access | Times Cited: 148
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 146
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 142
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 7, pp. 689-699
Open Access | Times Cited: 134
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 126
Count on us: T cells in SARS-CoV-2 infection and vaccination
Katherine Kedzierska, Paul G. Thomas
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100562-100562
Open Access | Times Cited: 118
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 10, pp. 951-963
Open Access | Times Cited: 117
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques
Jinyan Liu, Jingyou Yu, Katherine McMahan, et al.
Science Immunology (2022) Vol. 7, Iss. 77
Open Access | Times Cited: 115
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 109
SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters
Federico Armando, Georg Beythien, Franziska Kaiser, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 99
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 88
Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e172-e178
Open Access | Times Cited: 83
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 905-907
Open Access | Times Cited: 82
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 78
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1711-1724
Open Access | Times Cited: 72
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 69
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 53
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
T‐cell activation–induced marker assays in health and disease
Chad Poloni, Cole Schonhofer, Sabine Ivison, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 491-503
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top